Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-EN
Language French English
Date Updated 2019-12-03 2019-12-02
Drug Identification Number 02319624 02319624
Brand name OLMETEC PLUS OLMETEC PLUS
Common or Proper name Olmesartan medoxomil and hydrochlorothiazide tablets Olmesartan medoxomil and hydrochlorothiazide tablets
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL
Strength(s) 12.5MG 40MG 12.5MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30TAB 30TAB
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-12-04 2019-12-04
Actual start date 2019-12-02 2019-12-02
Estimated end date 2020-01-31 2020-01-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments